1.Wang Y*,Sheng L*, Han F,et al. Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: A systematic review and network meta-analysis. EClinicalMedicine. 2022 Dec 14;56:101777. (IF=15.1)
2.Wang T, Shi J, Li L, Zhou X, Zhang H, Zhang X, Wang Y, Liu L,Sheng L#. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma. Front Immunol 2022, 13. (IF=7.3)
3.Liang W, Shi J, Zhang H, Lv G, Wang T, Wang Y, Lv B, Li L, Zeng Q,Sheng L#. Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: A propensity-matched survival analysis. Surgery. 2022 Nov;172(5):1385-1391. (IF=3.8)
4. Li L, Li B, Lv B, Liang W, Zhang B, Zeng Q, Turner AG,Sheng L#. Increased thyroid malignancy in patients with primary hyperparathyroidism. Endocr Connect. 2021 Jul 1:EC-21-0217.R1. doi: 10.1530/EC-21-0217. (IF=3.3)
5.Sheng L*,Gao J*, Xu Q, et al. Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis. Ther Adv Med Oncol. 2021 May 29; 13: 17588359211018537.(IF=8.2)
6.Li L, Shan T, Sun X, Lv B, Chen B, Liu N, Zhang B, Hu S, Zeng Q, Turner AG,Sheng L#. Positive Thyroid Peroxidase Antibody and Thyroglobulin Antibody are Associated With Better Clinicopathologic Features of Papillary Thyroid Cancer. Endocr Pract. 2021 Apr;27(4):306-311. (IF=3.4)
7.Sheng L, Shi J, Han B, et al. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma. Am J Surg. 2020;220(2):334-340. (IF=2.1)
8. Zhou L, Chen B,Sheng L#, et al. The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis. Breast Cancer Res Treat. 2020;182(1):1-8. (IF=3.8)